Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Building a High-Value Health System
Introduction to the health of a population -- Assessing the health system of a country -- How did we get here? : historical megatrends in health and medical care -- Developing a vision and goals -- Developing plans for change : a framework for designing a high-value health system -- Testing the change, improving the plan -- Insights from systems thinking -- Implementing a change : adoption and diffusion -- So what, who cares? : the wrap-up.
The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS
Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and 1960s. Since 2008, the Forum on Drug Discovery, Development, and Translation of the Institute of Medicine has hosted or co-hosted six domestic and international workshops addressing the global crisis of drug-resistant TB, with special attention to the BRICS countries - Brazil, Russia, India, China, and South Africa. The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS is the summary of a workshop convened to address the current status of drug-resistant TB global...
Building a Culture of Health
This ambitious volume sets out to understand how every company impacts public health and introduces a robust model, rooted in organizational and scientific knowledge, for companies committed to making positive contributions to health and wellness. Focusing on four interconnected areas of corporate impact, it not only discusses the business imperative of promoting a healthier society and improved living conditions worldwide, but also provides guidelines for measuring a company’s population health footprint. Examples, statistics and visuals showcase emerging corporate involvement in public health and underscore the business opportunities available to companies that invest in health. The auth...
Closing the Cancer Divide
Cancer is a leading cause of death and disability in low- and middle-income countries. A cancer transition is increasing preventable risk, illness, impoverishment from illness, and death in poor populations. This book presents innovative strategies for strengthening health systems in response to the challenge of cancer and other chronic illnesses.
Artificial Intelligence Solutions for Global Health and Disaster Response: Challenges and Opportunities
Artificial intelligence (AI) has shown promise as an effective tool in disaster preparedness and response, providing a unique perspective on some of the most urgent health challenges. Rapid advances in AI technology can potentially revolutionize the way how we respond to emergencies and disasters that affect the world's health, including early warning systems, resource allocation, and real-time decision-making. This Research Topic aims to explore the latest developments in AI and its applications in global health and disaster response, providing a comprehensive overview of the potential and challenges of AI in improving health outcomes in crises. This Research Topic will bring together leading researchers, practitioners, and policymakers in global health and disaster response to share their experiences and insights on how AI can be leveraged to improve response efforts and enhance healthcare delivery.
Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed with multidrug-resistant tuberculosis (MDR TB)-a disease caused by strains of Mycobacterium tuberculosis (M.tb.) resistant to two primary TB drugs (isoniazid and rifampicin)-face lengthy treatment regimens of 2 years or more with daily, directly observed treatment (DOT) with SLDs that are less potent, more toxic, and more expensive than those used to treat drug-susceptible TB. From 2000 to 2009, only 0.2-0.5 percent o...
The Role of Public-Private Partnerships in Health Systems Strengthening
Over the past several decades, the public and private sectors made significant investments in global health, leading to meaningful changes for many of the world's poor. These investments and the resulting progress are often concentrated in vertical health programs, such as child and maternal health, malaria, and HIV, where donors may have a strategic interest. Frequently, partnerships between donors and other stakeholders can coalesce on a specific topical area of expertise and interest. However, to sustain these successes and continue progress, there is a growing recognition of the need to strengthen health systems more broadly and build functional administrative and technical infrastructur...
Nordic Health Care Systems: Recent Reforms And Current Policy Challenges
Examines patterns of health reform in Nordic health care systems, and the balance between stability and change in how these systems have developed. This book investigates the health systems in Norway, Denmark, Sweden and Finland through comparisons along a variety of policy-driven parameters.
Pharmaceutical Reform
This book applies an established analytical framework for health sector reform (Getting Health Reform Right, Oxford, 2004) to the performance problems of the pharmaceutical sector. The book is divided into three sections. The first section presents the basic ideas for analysis. It begins by insisting that reform start with a clear understanding of the performance deficiencies of the current system. Like all priority setting in the public sector, this 'definition of the problem' involves both ethical choices and political processes. Early chapters explain the foundations of these ideas and apply them to the pharmaceutical sector. The relationship of ultimate outcomes (like health status or ri...
The Routledge Handbook on Greening High-Density Cities
This new handbook provides a platform to bring together multidisciplinary researchers focusing on greening high-density agglomerations from three perspectives: climate change, social implications, and people’s health. Written by leading scholars and experts, the chapters aim to summarize the “state-of-the-art” and produce a reference book for policymakers, practitioners, academics, and researchers to study, design, and build high-density cities by integrating green spaces. The topics covered in the book include (but are not limited to) Urban Heat Island, Green Space and Carbon Sequestration, Green Space and Social Equity, Green Space and Public Health, Biophilic Cities, Urban Agriculture, Vertical Farms, Urban Farming Technologies, Nature and Biodiversity, Nature and Health, Biophilic Design, Green Infrastructure, Urban Revitalization, Post-Covid Cities, Smart and Resilient Cities, Tall Buildings, and Sustainable Vertical Cities.
